Pharmaceutical Business review

Hawthorn receives FDA approval for oral granisol solution

Granisol is the AA-rated equivalent of Roche’s Kytril oral solution. Granisol oral solution is available through all the national drug wholesalers as well as multiple other distribution channels and will begin shipping immediately. Granisol oral solution is available by prescription only in the US.

Chris Smith, vice president of sales at Hawthorn, said: “We feel this product will fill an important need in helping to prevent nausea and vomiting associated with chemotherapy or radiation for cancer therapy patients who may have difficulty swallowing tablets.”